Roche

As the world’s biggest biotech company and an innovator of products and services for the early detection, prevention, diagnosis and treatment of diseases, Roche contributes on a broad range of fronts to improving people’s health and quality of life.

The cobas h232 is a portable cardiac reader, designed for use in surgeries and surgeries.  It enables on the spot testing for DVT, pulmonary embolism, heart failure and myocardial infarction, delivering accuracy comparable to the laboratory and enabling swift diagnosis and treatment.
 

 

Web:
  • Send to a Colleague